The expression levels of a subset of eight genes, including dual specificity phosphatase 1 (DUSP1) and ubiquitin-specific protease 18 (USP18), have previously been used to predict the treatment response of patients with chronic hepatitis C [10]. This evidence concerns the gene DUSP1 and chronic hepatitis C virus infection.